Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis

INTRODUCTION: Patient-reported outcomes (PROs) provide an insightful method of assessing the subjective impact of therapies for those affected by multiple sclerosis (MS), a chronic neurologic disease notable for symptoms of fatigue and reduced physical function. The ongoing CLAWIR study aims to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Rau, Daniela, Müller, Beate, Übler, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611608/
https://www.ncbi.nlm.nih.gov/pubmed/37776477
http://dx.doi.org/10.1007/s12325-023-02682-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611608/
https://www.ncbi.nlm.nih.gov/pubmed/37776477
http://dx.doi.org/10.1007/s12325-023-02682-z

Ejemplares similares